Confluence Wealth Services Inc. lessened its position in shares of Corteva, Inc. (NYSE:CTVA – Free Report) by 2.9% during the second quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 5,579 shares of the company’s stock after selling 165 shares during the period. Confluence Wealth Services Inc.’s holdings in Corteva were worth $416,000 at the end of the most recent reporting period.
Several other large investors also recently added to or reduced their stakes in CTVA. Maryland Capital Advisors Inc. purchased a new position in shares of Corteva in the second quarter worth about $29,000. Valley National Advisers Inc. boosted its holdings in Corteva by 85.9% in the 1st quarter. Valley National Advisers Inc. now owns 526 shares of the company’s stock worth $33,000 after buying an additional 243 shares during the period. DHJJ Financial Advisors Ltd. grew its stake in Corteva by 132.2% in the 2nd quarter. DHJJ Financial Advisors Ltd. now owns 527 shares of the company’s stock valued at $39,000 after buying an additional 300 shares in the last quarter. Richardson Capital Management LLC bought a new stake in Corteva during the 1st quarter valued at $37,000. Finally, von Borstel & Associates Inc. purchased a new stake in shares of Corteva during the first quarter worth $44,000. Hedge funds and other institutional investors own 81.54% of the company’s stock.
Insider Activity at Corteva
In related news, EVP Robert D. King sold 37,280 shares of Corteva stock in a transaction that occurred on Friday, August 29th. The stock was sold at an average price of $74.20, for a total transaction of $2,766,176.00. Following the sale, the executive vice president directly owned 49,262 shares in the company, valued at $3,655,240.40. The trade was a 43.08% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. 0.14% of the stock is currently owned by insiders.
Analyst Ratings Changes
Get Our Latest Stock Analysis on Corteva
Corteva Stock Up 1.5%
Shares of Corteva stock opened at $64.30 on Tuesday. The company’s fifty day simple moving average is $71.08 and its two-hundred day simple moving average is $68.97. Corteva, Inc. has a 12-month low of $53.40 and a 12-month high of $77.41. The company has a current ratio of 1.68, a quick ratio of 1.23 and a debt-to-equity ratio of 0.06. The company has a market cap of $43.67 billion, a P/E ratio of 31.37, a PEG ratio of 1.43 and a beta of 0.76.
Corteva (NYSE:CTVA – Get Free Report) last announced its quarterly earnings results on Wednesday, August 6th. The company reported $2.20 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.89 by $0.31. Corteva had a net margin of 8.16% and a return on equity of 8.68%. The company had revenue of $6.46 billion for the quarter, compared to analysts’ expectations of $6.26 billion. During the same quarter in the previous year, the company earned $1.83 earnings per share. Corteva’s quarterly revenue was up 5.6% on a year-over-year basis. Research analysts anticipate that Corteva, Inc. will post 2.96 EPS for the current year.
Corteva Increases Dividend
The company also recently announced a quarterly dividend, which was paid on Monday, September 15th. Stockholders of record on Tuesday, September 2nd were given a $0.18 dividend. The ex-dividend date of this dividend was Tuesday, September 2nd. This represents a $0.72 annualized dividend and a dividend yield of 1.1%. This is an increase from Corteva’s previous quarterly dividend of $0.17. Corteva’s dividend payout ratio is currently 35.12%.
About Corteva
Corteva, Inc operates in the agriculture business. It operates through two segments, Seed and Crop Protection. The Seed segment develops and supplies advanced germplasm and traits that produce optimum yield for farms. It offers trait technologies that enhance resistance to weather, disease, insects, and herbicides used to control weeds, as well as food and nutritional characteristics.
See Also
- Five stocks we like better than Corteva
- Expert Stock Trading Psychology Tips
- Eli Lilly Stock Soars on Trump Tariff Hopes and Pfizer Deal
- Best of the list of Dividend Aristocrats: Build wealth with the aristocrat index
- 3 Exceptional Stocks to Build Long-Term Wealth
- 3 Warren Buffett Stocks to Buy Now
- Insider Sales Jump at Broadcom and CoreWeave: Red Flag Ahead?
Receive News & Ratings for Corteva Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Corteva and related companies with MarketBeat.com's FREE daily email newsletter.